about
Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral interventionRoles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Identification of c-MYC SUMOylation by mass spectrometry.Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseKPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancerA Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle.Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges.Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.Posttranslational modifications of lysine and evolving role in heart pathologies-recent developments.SUMO pathway components as possible cancer biomarkers.Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.Protein microarray applications: Autoantibody detection and posttranslational modification.The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.
P2860
Q26314693-CBF1D1BF-8287-4B82-B00D-82FDCBC38A79Q35380380-D2204ABD-44BF-466D-8914-1135CF2AC687Q35529775-12D4E3E2-DBB2-4A4D-892F-29352EF6D4F2Q35678658-F1B0106B-8326-49C9-AE57-DCB4740AD968Q36086823-6BA56C0A-9099-4B36-8AED-AFC54BA342D7Q36333305-459B07D9-465F-4EB6-BD4B-29FB9C0E9554Q36369146-5135E23F-C9E7-4D53-952B-F6E38676B78FQ38255299-2DCFA125-0DBE-438E-B01B-D8621C47AD4EQ38262063-FA9AB53F-30CD-470C-BCA6-21627E1B161EQ38272115-E7BAF4D0-7375-48B5-B301-4B534969F165Q38515816-2E6C5F79-910E-43B6-A6F5-58194F66EA38Q38900933-6812AF3F-1845-4A03-A36E-F52BEE27220DQ38907014-52CFDB97-8C46-44FD-A50F-1548B810C13DQ38907680-624EF6B4-C8DA-4648-877D-3DE7E805D946Q38998990-8ADCBDBD-307D-4E27-AE48-7CCB854B18E5Q41081937-2FB64761-0D63-4393-BE4A-38D3B436CB19Q42496885-1DC655A1-7B3D-45C4-A2BF-3CB4EB0294E5Q50437809-BA4F44BE-26BE-4FB1-A91F-72E19F2B2097
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
SUMOylation proteins in breast cancer.
@en
SUMOylation proteins in breast cancer.
@nl
type
label
SUMOylation proteins in breast cancer.
@en
SUMOylation proteins in breast cancer.
@nl
prefLabel
SUMOylation proteins in breast cancer.
@en
SUMOylation proteins in breast cancer.
@nl
P2093
P2860
P50
P1476
SUMOylation proteins in breast cancer.
@en
P2093
Alaa T Alshareeda
Christopher Nolan
Nada Albarakati
Rebeka Sultana
P2860
P2888
P304
P356
10.1007/S10549-014-2897-7
P407
P577
2014-03-01T00:00:00Z